Dr. med. Lorenz Bastian
![](https://www.catchall-kfo5010.com/wp-content/uploads/2022/04/Bastian_Lorenz-498x640.jpg)
Facts
Phone:
+49-431-500-22531
E-Mail:
lorenz.bastian@uksh.de
Website:
Affiliations:
Clinic for Internal Medicine II, Hematology and Oncology / University Medical Center Schleswig-Holstein, Campus Kiel
Address:
Arnold-Heller-Str. 3, Bldg L, 24105 Kiel
Curriculum vitae
Education/Training
Since 2020 | Head of the Molecular Tumor Board, Campus Kiel University Cancer Center Schleswig-Holstein, Kiel, Germany |
Since 2019 | Residency Internal Medicine and Hematology / Oncology, Clinic for Internal Medicine II, University Medical Center Schleswig-Holstein, Kiel, Germany |
2012-2018 | Residency Internal Medicine and Hematology / Oncology, Department of Medicine, Division of Hematology and Oncology, Charité – University Hospital Berlin, Germany |
2012 | Residency Internal Medicine, Department of Medicine, University Hospital Basel, Basel, Switzerland |
2009-2012 | Residency Pediatric Oncology and Hematology, Department of Pediatrics, Divison of Hematology and Oncology, Charité – University Hospital Berlin, Germany |
2008 | M. D. University Witten/Herdecke, Witten, Germany |
Research Experience/Academic Appointments
Since 2019 | Senior Clinician Scientist, Research Group Functional Genomics of Acute Leukemias (AG Prof. Dr. med. Claudia Baldus), University Medical Center Schleswig-Holstein, Kiel, Germany |
2015-2018 | Clinician Scientist, Clinician Scientist Program, Berlin Institute of Health, Berlin, Germany, Research Group Translational Leukemia Research, Charité – University Hospital Berlin, Germany and Fellow, DKTK School of Oncology, German Cancer Consortium, Heidelberg, Germany |
2016-2018 | DKTK Investigator, German Cancer Consortium and German Cancer Research Center, Berlin and Heidelberg, Germany |
2008-2014 | Doctoral and Post-doctoral Researcher, Department of Pediatrics, Division of Hematology and Oncology, Charité – University Hospital Berlin, Germany |
Important Scientific Prizes/Functions
2019 | Poster prize, EMBO Workshop on “B cell development and leukemia”, Salamanca, Spain |
2017 | ASH Abstract Achievement Award, American Society of Hematology, Atlanta, USA |
2015 | ASH Abstract Achievement Award, American Society of Hematology, Orlando, USA |
Project-related publications
P1, P3, P4, INF
Insights into IGH clonal evolution in BCP-ALL: frequency, mechanisms, associations, and diagnostic implications
P1, P3, P4, INF, Z
The Gene Expression Classifier ALLCatchR Identifies B-cell Precursor ALL Subtypes and Underlying Developmental Trajectories Across Age
P1, P3, P4, Z, INF
Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL.
P1, P3, P4, INF, Z
UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment
P3, P4, P6, P7, Z
Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALL
P1, P3, P4, INF, Z
IGH Rearrangement Evolution in Adult KMT2Arearranged B-cell Precursor ALL: Implications for Cell-of-origin and MRD Monitoring
P1, P4, P6
In vivo inducible reverse genetics in patients’ tumors to identify individual therapeutic targets
P1, P3, P4, Z